NCT03492060 Longitudinal Study of Neurogenetic Disorders
| NCT ID | NCT03492060 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Neurodevelopmental Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-06-13 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-06-13 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to analyze patterns in individuals with hnRNP (and other) genetic variants, including their neurological comorbidities, other medical problems and any treatment. The investigators will maintain an ongoing database of medical data that is otherwise being collected for routine medical care. The investigators will also collect data prospectively in the form of questionnaires, neuropsychological assessments, motor assessments, and electroencephalography to examine the landscape of deleterious variants in these genes.
Eligibility Criteria
Inclusion Criteria: * Individuals must have had whole genome/exome sequencing and have a confirmed variant in any gene. Exclusion Criteria: * Subjects who cannot provide genetic confirmation of a predicted deleterious variant in any gene.
Contact & Investigator
Jennifer M. Bain, MD, PhD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT03492060 clinical trial?
This trial is open to participants of all sexes, studying Neurodevelopmental Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03492060 currently recruiting?
Yes, NCT03492060 is actively recruiting participants. Contact the research team at jb3634@cumc.columbia.edu for enrollment information.
Where is the NCT03492060 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT03492060 clinical trial?
NCT03492060 is sponsored by Columbia University. The principal investigator is Jennifer M. Bain, MD, PhD at Columbia University. The trial plans to enroll 1,000 participants.